ATE187202T1 - Nukleotidsequenzen die fur proteine von cryptosporidium kodieren, polypeptide, welche durch diese sequenzen kodiert werden, und kits fur deren benutzung - Google Patents
Nukleotidsequenzen die fur proteine von cryptosporidium kodieren, polypeptide, welche durch diese sequenzen kodiert werden, und kits fur deren benutzungInfo
- Publication number
- ATE187202T1 ATE187202T1 AT93919553T AT93919553T ATE187202T1 AT E187202 T1 ATE187202 T1 AT E187202T1 AT 93919553 T AT93919553 T AT 93919553T AT 93919553 T AT93919553 T AT 93919553T AT E187202 T1 ATE187202 T1 AT E187202T1
- Authority
- AT
- Austria
- Prior art keywords
- kits
- cryptosporidium
- polypeptides encoded
- sequences
- nucleotide sequences
- Prior art date
Links
- 241000223935 Cryptosporidium Species 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 238000003556 assay Methods 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 244000000040 protozoan parasite Species 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM920603A IT1262975B (it) | 1992-08-13 | 1992-08-13 | La sequenza dell'inserto cprl3, parte del gene della proteina della oociste di cryptosporidium (cowp), e derivati utili per la diagnosi dell'infezione da cryptosporidium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE187202T1 true ATE187202T1 (de) | 1999-12-15 |
Family
ID=11401156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93919553T ATE187202T1 (de) | 1992-08-13 | 1993-08-10 | Nukleotidsequenzen die fur proteine von cryptosporidium kodieren, polypeptide, welche durch diese sequenzen kodiert werden, und kits fur deren benutzung |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0656063B1 (de) |
| AT (1) | ATE187202T1 (de) |
| AU (1) | AU4981093A (de) |
| DE (1) | DE69327167D1 (de) |
| IT (1) | IT1262975B (de) |
| WO (1) | WO1994004681A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU680615B2 (en) * | 1992-05-29 | 1997-08-07 | Regents Of The University Of California, The | (Cryptosporidium) polypeptides, nucleic acid, vectors and methods of use |
| DE4408700C1 (de) * | 1994-03-15 | 1995-04-13 | Albrecht Dr Med Wiedenmann | Selektiver Nachweis lebender, infektionsfähiger Cryptosporidien-Oozysten mit Hilfe der Polymerase-Kettenreaktion (PCR) |
| US5693472A (en) * | 1995-06-07 | 1997-12-02 | The Board Of Regents Of The University Of Oklahoma | Detection of cryptosporidium parvum |
| AUPN391695A0 (en) * | 1995-06-30 | 1995-07-27 | Murdoch University | Diagnostic assay |
| US5888748A (en) * | 1995-07-13 | 1999-03-30 | Immucell Corporation | Methods and articles of manufacture for the detection of cryptosporidium occysts |
| US5770368A (en) * | 1996-05-09 | 1998-06-23 | Metropolitan Water District Of Southern California | Cryptosporidium detection method |
| AU2002211814A1 (en) | 2000-09-12 | 2002-03-26 | Gen-Probe Incorporated | Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample |
-
1992
- 1992-08-13 IT ITRM920603A patent/IT1262975B/it active IP Right Grant
-
1993
- 1993-08-10 AT AT93919553T patent/ATE187202T1/de not_active IP Right Cessation
- 1993-08-10 EP EP93919553A patent/EP0656063B1/de not_active Expired - Lifetime
- 1993-08-10 AU AU49810/93A patent/AU4981093A/en not_active Abandoned
- 1993-08-10 WO PCT/IT1993/000089 patent/WO1994004681A1/en not_active Ceased
- 1993-08-10 DE DE69327167T patent/DE69327167D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0656063B1 (de) | 1999-12-01 |
| DE69327167D1 (de) | 2000-01-05 |
| ITRM920603A0 (it) | 1992-08-13 |
| AU4981093A (en) | 1994-03-15 |
| EP0656063A1 (de) | 1995-06-07 |
| IT1262975B (it) | 1996-07-23 |
| ITRM920603A1 (it) | 1994-02-13 |
| WO1994004681A1 (en) | 1994-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60032355D1 (de) | Neuroprotektive eigenschaften von gdf-15, ein mitglied der tgf-beta superfamilie | |
| DE69131249D1 (de) | Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen | |
| ATE315654T1 (de) | Diagnose und behandlung von mit aur-1 und/oder aur-2 assoziierten erkrankungen | |
| ATE135371T1 (de) | Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis | |
| ATE516304T1 (de) | Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden | |
| KR890700666A (ko) | 혈관 항응고 단백질, 이를 암호화하는 dna, 이의 제조방법 및 용도 | |
| BR9106220A (pt) | Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c. | |
| ATE380867T1 (de) | Lactoferrinrezeptorgen von moraxella | |
| SE8801701D0 (sv) | Production technology based on enzymic method | |
| ATE327328T1 (de) | Adipozyten-spezifische protein homologe | |
| ES2079621T3 (es) | Procedimiento de identificacion o de titulacion de proteinas y aplicaciones. | |
| DE68929334D1 (de) | Verfahren zumm Assay von Endotoxin-Konzentration | |
| ATE271603T1 (de) | Identifizierungsverfahren für substanzen die an das pyk2 polypeptid binden | |
| DE3881023D1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
| ATE187202T1 (de) | Nukleotidsequenzen die fur proteine von cryptosporidium kodieren, polypeptide, welche durch diese sequenzen kodiert werden, und kits fur deren benutzung | |
| ATE349533T1 (de) | Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen | |
| FI860677A7 (fi) | Rhinoviruskannan HRV2 polypeptidi ja sitä koodaava DNA-molekyyli. | |
| DE69728897D1 (de) | Saeugetierchemokine | |
| ATE331032T1 (de) | Glutamine: fructose-6-phosphat amidotransferase (gfat), ihre herstellung und verwendung | |
| DE3853693D1 (de) | DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung. | |
| ATE122723T1 (de) | Retinoblastoma-genprodukt-antikörper und deren verwendungen. | |
| DE69233673D1 (de) | Protein S polypeptide und deren Verwendungen | |
| DE69033553D1 (de) | Rekombinante herstellung von laktoperoxidase | |
| ATE180497T1 (de) | Quecksilberbindende polypeptide und diese kodierende nukleotide | |
| KR960041193A (ko) | 생물학적 활성을 나타내는 폴리펩티드 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |